Physician profile
Robert Scott Davis
NPI 1649378191
$6,272.08
in general payments reported to CMS, 2019-2025
9 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $21.98 · 2023: $4,308 · 2024: $1,579 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,752 · Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,752.38 |
| Food and Beverage | $1,354.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $2,567.99 | 2023 | Perla C, Perla Tl |
| Spinal Simplicity, LLC | $1,910.70 | 2023-2025 | Ha Minuteman G3-R, Liberty Si |
| Abbott Laboratories | $1,504.69 | 2023 | Proclaim |
| Life Spine, INC. | $142.91 | 2019 | |
| Si-Bone, INC. | $56.23 | 2023 | |
| Xtant Medical INC | $26.23 | 2023 | |
| Captiva Spine INC | $24.14 | 2023 | Transfasten |
| Allergan, INC. | $21.98 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.21 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.